Table 4.
Microbial resistance patterns detected by phenotypic screening among Campylobacter jejuni.
| Campylobacter jejuni | ||||||||
|---|---|---|---|---|---|---|---|---|
| Antibiotic | No. of Resistance Human Isolates | Human Isolates | Resistance Ratio/Human Isolates | No. of Resistance Animal Isolates | Animal Isolates | Resistance Ratio/Animal Isolates | Relative Risk | 95%CI |
| Amoxicillin–Clavulanic acid | 283 | 416 | 68% | 56 | 173 | 32% | 0.79 | [0.67; 0.95] |
| Amoxicillin | 297 | 297 | 100% | 52 | 52 | 100% | 1 | [0.96; 1.04] |
| Ampicillin | 466 | 579 | 81% | 142 | 223 | 64% | 1 | [0.97; 1.03] |
| Azithromycin | 261 | 297 | 88% | 52 | 52 | 100% | 1.13 | [1.04; 1.24] |
| Chloramphenicol | 258 | 316 | 82% | 50 | 73 | 69% | 1.01 | [0.89; 1.14] |
| Ciprofloxacin | 460 | 627 | 73% | 187 | 265 | 71% | 0.92 | [0.84; 1.01] |
| Erythromycin | 393 | 608 | 65% | 92 | 244 | 38% | 1 | [0.97; 1.03] |
| Nalidixic acid | 558 | 627 | 89% | 201 | 265 | 76% | 0.89 | [0.77; 1.02] |
| Streptomycin | 213 | 544 | 39% | 50 | 235 | 21% | 1.02 | [0.83; 1.26] |
| Tetracycline | 248 | 330 | 75% | 119 | 213 | 56% | 0.94 | [0.84; 1.05] |
| Trimethoprim–sulfamethoxazole | 371 | 399 | 93% | 85 | 103 | 83% | 1.01 | [0.97; 1.04] |